Quaker Wealth Management’s Sarepta Therapeutics SRPT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$7.29K Hold
400
– – ﹤0.01% 315
2026
Q2
$7.19K Hold
400
– – ﹤0.01% 311
2026
Q1
$8.7K Hold
400
– – ﹤0.01% 304
2025
Q4
$8.61K Hold
400
– – ﹤0.01% 310
2025
Q3
$7.71K Hold
400
– – ﹤0.01% 296
2025
Q2
$6.84K Buy
+400
New +$17.1K ﹤0.01% 314

Other funds holding SRPT

Quaker Wealth Management's SRPT Position: Q3 2026 in Review

Quaker Wealth Management held its Sarepta Therapeutics (SRPT) position steady in Q3 2026 at 400 shares worth $7.29K. The position accounts for ﹤0.01% of the portfolio, ranked #315.

Quaker Wealth Management first reported a position in SRPT in Q2 2025 and has held it in 6 quarters since. The position peaked at $8.7K in Q1 2026. 305 funds tracked by Wall St. Rank hold SRPT as of Q3 2026.

  • Quaker Wealth Management held 400 shares of Sarepta Therapeutics worth $7.29K as of Q3 2026.
  • Quaker Wealth Management left its Sarepta Therapeutics share count unchanged in Q3 2026.
  • Sarepta Therapeutics made up ﹤0.01% of Quaker Wealth Management's portfolio in Q3 2026, its #315 holding.
  • Quaker Wealth Management first reported a position in Sarepta Therapeutics in Q2 2025 and has held it in 6 quarters since.
  • Quaker Wealth Management's Sarepta Therapeutics position peaked at $8.7K in Q1 2026.
  • 305 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q3 2026.

Based on Quaker Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.